VEGFA and neoplasm: Overall, our results suggest that in addition to the antiangiogenic activity of anti-VEGF-A on endothelial cells, this treatment strategy may also inhibit the angiogenic properties of MPs shed from tumor cells in an anti-VEGF-A microenvironment.